Filing Details

Accession Number:
0001645470-19-000002
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2019-01-14 15:09:32
Reporting Period:
2015-06-15
Accepted Time:
2019-01-14 15:09:32
Original Submission Date:
2019-01-14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1528172 Endonovo Therapeutics Inc. ENDV Pharmaceutical Preparations (2834) 452552528
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1645470 Brian Alan Collier 6320 Canoga Avenue
15Th Floor
Woodland Hills CA 91367
Ceo No Yes No No
Transaction Summary
Purchased: 20,601,123 shares Avg. Price: $0.00 Total Value: $852.00
Number of Shares After Transactions: 20,601,123 shares
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-06-15 19,226,657 $0.00 19,226,657 No 4 P Indirect held by minor children and other entities
Common Stock Acquisiton 2015-06-15 329,466 $0.00 19,556,123 No 4 P Direct
Common Stock Acquisiton 2016-06-20 1,000,000 $0.00 20,556,123 No 4 P Direct
Common Stock Acquisiton 2019-01-09 10,000 $0.02 20,566,123 No 4 P Direct
Common Stock Acquisiton 2019-01-09 10,000 $0.02 20,576,123 No 4 P Direct
Common Stock Acquisiton 2019-01-09 10,000 $0.02 20,586,123 No 4 P Direct
Common Stock Acquisiton 2019-01-09 5,000 $0.02 20,591,123 No 4 P Direct
Common Stock Acquisiton 2019-01-09 5,000 $0.02 20,596,123 No 4 P Direct
Common Stock Acquisiton 2019-01-09 5,000 $0.02 20,601,123 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect held by minor children and other entities
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. Company grant